诺和诺德下一代减重新药挺进 III 期

丁香园 Insight 数据库
Jan 15

当地时间 1 月 14 日,诺和诺德在 ClinicalTrials 官网登记了一项NNC0487-0111皮下注射每周一次治疗肥胖人群的III 期临床。公开资料显示,这是该药启动的首个 III 期。来源:ClinicalTrials 官网该研究拟纳入 1150 人,将排除此前接受过 GLP-1 RA、双重 GLP-1/GIP RA(或任何其他基于 GLP-1 的治疗)治疗的受试者。受试者将被随机...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10